Blood test may reveal which lymphoma patients will respond to immunotherapy
Cornell engineers and Dana-Farber oncologists found that RNA floating in the plasma carries a signature of a lymphoma tumor's surroundings, one that tracked with whether patients were still in remission a year later.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.